Rhinomed
Manufacturing · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
41 Madison Ave Fl 31, New York City, New...Phone Number
(866) 316-0671Website
rhinomed.globalRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Rhinomed
Rhinomed is a global medical device company specializing in wearable nasal technology aimed at enhancing respiration, sleep, and the diagnosis of upper respiratory diseases. Their product range includes solutions for snoring, sports performance, and respiratory sample collection, including the world's first nasal swab designed specifically for children. Rhinomed's innovations, such as the Mute and Turbine devices, help improve nasal breathing and airflow, while their Rhinoswab products standardize and simplify the process of collecting respiratory samples. The company targets a wide audience, including individuals seeking better sleep, athletes, and healthcare providers looking for effective diagnostic tools.Explore more
Rhinomed Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rhinomed your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Rhinomed has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Rhinomed has new funding data
Earning: See what the market has to say on Rhinomed recently announced quarterly report
Rhinomed, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Rhinomed launches new products
Click to see if Rhinomed had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Rhinomed
Check out if Rhinomed is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Rhinomed
Compare insights from companies similar to Rhinomed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Rhinomed is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Rhinomed is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Rhinomed.
Rhinomed financials insights
Gather financial insights about Rhinomed, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Private Equity
$6M
Rhinomed Tech Stack
A closer look at the technologies used by Rhinomed
Most Recent Scoops
Funding
Funding
Earnings
Rhinomed has recently released 2024 Q1 report with the following insight: Key goals include growing the consumer health business by expanding retail distribution and increasing product sales velocity. Rapid antigen test kit regulatory approval and bringing integrated swab solutions to market is another core goal. The company also aims to leverage its consumer health retail presence to distribute any approved test kits. Operationally, RHINOMED is focused on reducing costs and aligning spending to revenue growth.
Product Development, Sales, Business Development, Sales Development
Event
will be attending the 2022 AACC Annual Scientific Meeting + Clinical Lab Expo conference as an exhibitor. The event will occur from July 24 to July 28, 2022.
Event
Rhinomed News & Media
Insider Buyers Lose AU$435k As Rhinomed Sheds AU$1.4m
The recent 14% drop in Rhinomed Limited's ( ASX:RNO ) stock could come as a blow to insiders who purchased AU$624.8k...Q+A: How is Rhinomed shaping nasal technology?
Michael Johnson, CEO of Rhinomed, discusses the latest nasal technology.Meredith George Bought 6.7% More Shares In Rhinomed \
Investors who take an interest in Rhinomed Limited ( ASX:RNO ) should definitely note that insider Meredith George...Meredith George Just Bought 8.2% More Shares In Rhinomed Limited (ASX:RNO)
Potential Rhinomed Limited ( ASX:RNO ) shareholders may wish to note that insider Meredith George recently bought...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rhinomed
Sign Up For FreeTo access detailed company insights
Rhinomed is a global medical device company specializing in wearable nasal technology aimed at enhancing respiration, sleep, and the diagnosis of upper respiratory diseases. Their product range includes solutions for snoring, sports performance, and respiratory sample collection, including the world's first nasal swab designed specifically for chil... Read More
